In patients with acute hypoxemic respiratory failure whose diagnosis is not established after initial evaluation, obtaining a histopathological diagnosis may improve the patients' prognosis. In our previous retrospective-controlled study, transbronchial lung cryobiopsy (TBLC) can lead to an increased chance of establishing a diagnosis compared with transbronchial lung biopsy (TBLB), with an acceptable safety profile. Therefore, further prospective randomized controlled studies exploring whether TBLC leads to improved prognosis for such patients are warranted.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Enrollment
100
Lung tissue was obtained by transbronchial lung cryobiopsy for subsequent pathology and clinical diagnosis.
Lung tissue was obtained by transbronchial lung biopsy for subsequent pathology and clinical diagnosis.
China-Japan Friendship Hospital
Beijing, China
RECRUITINGThe Second Xiangya Hospital
Changsha, China
RECRUITINGThe First Affiliated Hospital of Nanchang University
Nanchang, China
RECRUITINGThe First Affiliated Hospital of Soochow University
Suzhou, China
RECRUITINGThe Sixth Hospital of Wuhan
Wuhan, China
RECRUITINGThe First Affiliated Hospital of Zhengzhou University
Zhengzhou, China
RECRUITINGDiagnostic yield
The diagnostic yield of each procedure.
Time frame: 7 days after procedure
Mortality
The 28-day and 60-day of patients in each group.
Time frame: 28 and 60 days
Incidence of procedure related adverse events
Procedure related death, procedure related hemodynamic and respiratory instability, airway bleeding, pneumothorax and other procedure related adverse events.
Time frame: 3 days after procedure
Hospital stay
Length of hospital stay including ICU and general ward of respiratory medicine.
Time frame: up to 60 days
Organ support
Length of organ support (days).
Time frame: up to 60 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.